"Pharmacy Benefit Manager (PBM) arrangements have long relied on rebates with limited transparency into true drug costs. Recent regulatory and market developments represent a shift toward greater transparency and better net pricing. These developments span a broad range of actors and approaches, including increased regulation of PBMs by the states, legislative, rule-making and agency actions by the federal government, and evolving market-driven responses. This post provides a high‑level overview of key developments and offers practical steps for health plan fiduciaries to consider[.]"  MORE >>